According to HKEx information, US Capital Group's shareholding ratio in Hengrui Pharmaceutical's H shares rose from 9.86% to 10.04% on July 29, and the average share price purchased was HK$57.9041.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.